Glofitamab: a valuable agent for the treatment of patients with R/R mantle cell lymphoma

Glofitamab: a valuable agent for the treatment of patients with R/R mantle cell lymphoma

New Agents for Mantle Cell LymphomaПодробнее

New Agents for Mantle Cell Lymphoma

A Phase I/II trial of glofitamab monotherapy in R/R MCLПодробнее

A Phase I/II trial of glofitamab monotherapy in R/R MCL

Update on Phase I/II study of glofitamab monotherapy in R/R MCLПодробнее

Update on Phase I/II study of glofitamab monotherapy in R/R MCL

Mantle Cell Lymphoma (Case Studies)Подробнее

Mantle Cell Lymphoma (Case Studies)

Phase II study of glofitamab in patients with R/R LBCLПодробнее

Phase II study of glofitamab in patients with R/R LBCL

Tycel Phillips, MD, on Glofitamab Research, Progress in Mantle Cell LymphomaПодробнее

Tycel Phillips, MD, on Glofitamab Research, Progress in Mantle Cell Lymphoma

Glofitamab & Pirtobrutinib for Relapsed/Refractory Mantle Cell Lymphoma -Blood Cancers Video LibraryПодробнее

Glofitamab & Pirtobrutinib for Relapsed/Refractory Mantle Cell Lymphoma -Blood Cancers Video Library

Glofitamab as a single agent in heavily pretreated patients with DLBCLПодробнее

Glofitamab as a single agent in heavily pretreated patients with DLBCL

Glofitamab and obinutuzumab in r/r MCLПодробнее

Glofitamab and obinutuzumab in r/r MCL

GLOBRYTE: investigating glofitamab monotherapy in patients with R/R MCLПодробнее

GLOBRYTE: investigating glofitamab monotherapy in patients with R/R MCL

Debate: Relapsed Mantle Cell Lymphoma - Ibrutinib based Therapy AloneПодробнее

Debate: Relapsed Mantle Cell Lymphoma - Ibrutinib based Therapy Alone

The role of targeted therapies in the frontline treatment of mantle cell lymphomaПодробнее

The role of targeted therapies in the frontline treatment of mantle cell lymphoma

Glofitamab step-up dosing in R/R MCLПодробнее

Glofitamab step-up dosing in R/R MCL

Expert Reviews Treatment Landscape for Patients With Mantle Cell LymphomaПодробнее

Expert Reviews Treatment Landscape for Patients With Mantle Cell Lymphoma

Ibrutnib in Older Patients With Mantle Cell LymphomaПодробнее

Ibrutnib in Older Patients With Mantle Cell Lymphoma

Understanding Mantle Cell Lymphoma with Jia Ruan, MD, Ph.D.Подробнее

Understanding Mantle Cell Lymphoma with Jia Ruan, MD, Ph.D.

Promising agents being explored in R/R MCL: bispecific antibodies and BTK inhibitorsПодробнее

Promising agents being explored in R/R MCL: bispecific antibodies and BTK inhibitors

Rule Discusses the Potential of Zanubrutinib in the Treatment of Mantle Cell LymphomaПодробнее

Rule Discusses the Potential of Zanubrutinib in the Treatment of Mantle Cell Lymphoma

Standard Regimens and Novel Agents for Mantle Cell LymphomaПодробнее

Standard Regimens and Novel Agents for Mantle Cell Lymphoma